Okay, then, let me ask this question, and I know you will want to jump in.
Right now drug regulation in Canada is completely shrouded in secrecy. What we're talking about is a very marked departure. Today even the names of drugs in the approval process are not disclosed. All the information that industry submits, including clinical trial data on safety and effectiveness, is deemed confidential, and it can only be released with the permission of the company, even when you have an access to information request. So we're talking about a complete departure from that.
I want to know if you're in agreement, because this gets to the heart of the overall issues around drug surveillance.
Yola...and maybe the others.